NCT05979584 - Platelet Rich Plasma VS Platelet Fibrin Plasma in Treatment of Diabetes Related Wound：a Randomized Controlled Trial | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 20, 2023

Primary Completion Date

March 4, 2025

Study Completion Date

March 9, 2025

Conditions

Diabetic Foot

Interventions

DEVICE

Platelet Fibrin Plasma

Participants of intervention group will receive Platelet Fibrin Plasma in addition with clinical optimal treatment plan after the wound bed preparation for closure.

DEVICE

Platelet Rich Plasma

Participants of intervention group will receive Platelet Rich Plasma in addition with clinical optimal treatment plan after the wound bed preparation for closure.

Trial Locations (1)

010

Peking University 3rd Hospital, Beijing

All Listed Sponsors

lead

Peking University Third Hospital

OTHER